Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about APOE Ε4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | APOE Ε4 |
| Key Genes/Proteins | ABCG1, ALZHEIMER, ALZHEIMER DISEASE, ALZHEIMER'S DISEASE, AMYLOID, AMYLOID-BETA |
| Related Diseases | Aging, ALS, Alzheimer, Alzheimer's Disease, Anxiety |
| Related Pathways | Amyloid |
graph TD
APOE__4["APOE Epsilon4"]
style APOE__4 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
APOE__4 -->|"risk_factor_for"| Alzheimer_s_Disease["Alzheimer's Disease"]
APOE__4 -.->|"inhibits"| Neuroprotection["Neuroprotection"]
APOE__4 -->|"upregulates"| STING([STING])
APOE__4 -.->|"biomarker for"| Alzheimer["Alzheimer"]
APOE__4 -.->|"biomarker for"| Neuroinflammation["Neuroinflammation"]
APOE__4 -.->|"biomarker for"| ALS["ALS"]
APOE__4 -.->|"biomarker for"| Inflammation["Inflammation"]
APOE__4 -->|"activates"| Neurodegeneration["Neurodegeneration"]
APOE__4 -->|"activates"| Dementia["Dementia"]
NEUROINFLAMMATION([NEUROINFLAMMATION]) -.->|"biomarker for"| APOE__4
CYTOKINES([CYTOKINES]) -.->|"biomarker for"| APOE__4
IL9([IL9]) -.->|"biomarker for"| APOE__4
PDGFRB([PDGFRB]) -.->|"biomarker for"| APOE__4
AMYLOID([AMYLOID]) -.->|"biomarker for"| APOE__4
NPTX1([NPTX1]) -.->|"biomarker for"| APOE__4
CHI3L1([CHI3L1]) -.->|"biomarker for"| APOE__4
AMYLOID_BETA([AMYLOID-BETA]) -.->|"biomarker for"| APOE__4
INFLAMMATION([INFLAMMATION]) -.->|"biomarker for"| APOE__4
NEFL([NEFL]) -.->|"biomarker for"| APOE__4| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer's disease | associated_with | disease | 1.00 |
| Alzheimer Disease | risk_factor_for | disease | 0.95 |
| amyloid-beta plaque deposition | promotes | process | 0.93 |
| Aβ aggregation | causes | mechanism | 0.90 |
| tau spreading | causes | mechanism | 0.90 |
| Alzheimer's disease | causes | disease | 0.90 |
| AD | risk_factor_for | disease | 0.90 |
| Alzheimer's Disease | risk_factor_for | disease | 0.90 |
| brain lipid metabolism | disrupts | pathway | 0.90 |
| cognitive impairment | causes | process | 0.90 |
| Alzheimer disease | risk_factor_for | disease | 0.90 |
| distinct genetic form of AD | causes | phenotype | 0.90 |
| late-onset Alzheimer's disease | associated_with | disease | 0.90 |
| cortical Aβ burden | causes | biomarker | 0.90 |
| NEUTROPHILS | interacts_with | cell_type | 0.90 |
| MICROGLIA | interacts_with | cell_type | 0.90 |
| cognitive decline | causes | pathway | 0.90 |
| SV2A | downregulates | protein | 0.88 |
| pS65-Ub | associated_with | biomarker | 0.85 |
| Age of Onset | modulates | phenotype | 0.85 |
| Neuroprotection | inhibits | process | 0.85 |
| STING | upregulates | protein | 0.80 |
| cerebral amyloid angiopathy | associated_with | disease | 0.80 |
| microglia | disrupts | cell_type | 0.80 |
| cognitive decline | associated_with | pathway | 0.80 |
| cerebral amyloid angiopathy burden | increases | pathology | 0.70 |
| p-tau217 normalization | delays | process | 0.70 |
| synaptic vulnerability | causes | mechanism | 0.70 |
| vascular dysfunction | causes | mechanism | 0.70 |
| microglial activation | causes | mechanism | 0.70 |
| Anxiety | protects_against | disease | 0.65 |
| Diabetes | protects_against | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Dementia | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Alzheimer | biomarker_for | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Neuroinflammation | biomarker_for | disease | 0.65 |
| Inflammation | biomarker_for | disease | 0.65 |
| ALS | biomarker_for | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| CYP46A1 | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ASTROCYTE | associated_with | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| APOE4 | activates | gene | 0.60 |
| PLCG2 | interacts_with | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| FGF2 | biomarker_for | gene | 0.60 |
| IL4 | biomarker_for | gene | 0.60 |
| TAU PATHOLOGY | biomarker_for | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| CLU | associated_with | gene | 0.60 |
| ANXIETY | protects_against | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| MICROGLIA | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| NEUROINFLAMMATION | biomarker_for | gene | 0.60 |
| CYTOKINES | biomarker_for | gene | 0.60 |
| IL9 | biomarker_for | gene | 0.60 |
| PDGFRB | biomarker_for | gene | 0.60 |
| AMYLOID | biomarker_for | gene | 0.60 |
| NPTX1 | biomarker_for | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| CHI3L1 | biomarker_for | gene | 0.60 |
| AMYLOID-BETA | biomarker_for | gene | 0.60 |
| INFLAMMATION | biomarker_for | gene | 0.60 |
| NEFL | biomarker_for | gene | 0.60 |
| MDH1 | biomarker_for | gene | 0.60 |
| BDNF | biomarker_for | gene | 0.60 |
| ALZHEIMER'S DISEASE | biomarker_for | gene | 0.60 |
| CHIT1 | biomarker_for | gene | 0.60 |
| TAU | biomarker_for | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| APOE | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| APP | activates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| CGAS | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| APP | inhibits | gene | 0.60 |
| ALZHEIMER DISEASE | associated_with | gene | 0.60 |
| MICROGLIA | inhibits | gene | 0.60 |
| PSEN1 | activates | gene | 0.60 |
| PSEN2 | activates | gene | 0.60 |
| DEMENTIA | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| DEMENTIA | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| APOE ε4 Drives Lipid Droplet Accumulation in a Unique Lipid- | 0.685 | Alzheimer disease | APOE ε4 Lipid Metabolism Differences in |
| APOE ε4-driven microglial lipid handling as proximal driver | 0.626 | neurodegeneration | Non-Neuronal Transcriptional Changes Pre |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.585
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.380
neurodegeneration | 2026-04-16 | 3 hypotheses Top: 0.877
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 1.00 · 2026-04-26
closed · Rounds: 4 · Score: 0.70 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
Hypotheses and analyses mentioning APOE Ε4 in their description or question text
No additional research found